Myeloid cells

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.
Post Reply
User avatar
Petr75
Family Elder
Posts: 1126
Joined: Sat Oct 19, 2013 10:17 am
Location: Czech Republic

Myeloid cells

Post by Petr75 » Sun Apr 19, 2020 3:04 am

2020 Jun 1
Department of Neurology, Focus Program Translational Neuroscience and Immunotherapy, Rhine Main Neuroscience Network, University Medical Center of the Johannes Gutenberg University Mainz, Germany
CNS-localized myeloid cells capture living invading T cells during neuroinflammation.
https://www.ncbi.nlm.nih.gov/pubmed/32219436

Abstract

To study the role of myeloid cells in the central nervous system (CNS) in the pathogenesis of multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), we used intravital microscopy, assessing local cellular interactions in vivo in EAE animals and ex vivo in organotypic hippocampal slice cultures. We discovered that myeloid cells actively engulf invading living Th17 lymphocytes, a process mediated by expression of activation-dependent lectin and its T cell-binding partner, N-acetyl-D-glucosamine (GlcNAc). Stable engulfment resulted in the death of the engulfed cells, and, remarkably, enhancement of GlcNAc exposure on T cells in the CNS ameliorated clinical EAE symptoms. These findings demonstrate the ability of myeloid cells to directly react to pathogenic T cell infiltration by engulfing living T cells. Amelioration of EAE via GlcNAc treatment suggests a novel first-defense pathway of myeloid cells as an initial response to CNS invasion and demonstrates that T cell engulfment by myeloid cells can be therapeutically exploited in vivo.

User avatar
Petr75
Family Elder
Posts: 1126
Joined: Sat Oct 19, 2013 10:17 am
Location: Czech Republic

Re: Myeloid cells

Post by Petr75 » Mon Nov 16, 2020 11:49 am

2020 Oct 6
Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago
Potential for Targeting Myeloid Cells in Controlling CNS Inflammation
https://pubmed.ncbi.nlm.nih.gov/33123148/

Abstract

Multiple Sclerosis (MS) is characterized by immune cell infiltration to the central nervous system (CNS) as well as loss of myelin. Characterization of the cells in lesions of MS patients revealed an important accumulation of myeloid cells such as macrophages and dendritic cells (DCs). Data from the experimental autoimmune encephalomyelitis (EAE) model of MS supports the importance of peripheral myeloid cells in the disease pathology. However, the majority of MS therapies focus on lymphocytes. As we will discuss in this review, multiple strategies are now in place to target myeloid cells in clinical trials. These strategies have emerged from data in both human and mouse studies. We discuss strategies targeting myeloid cell migration, growth factors and cytokines, biological functions (with a focus on miRNAs), and immunological activities (with a focus on nanoparticles).

Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “General Discussion”